About this trial
Summary The Lupus Foundation of America (LFA) Research Accelerated by You (RAY) Registry is a fully remote, longitudinal registry designed to collect data from adults and children living with lupus. The primary goal is to better understand the diagnosis, treatment, care, and quality of life for those affected by the disease.
Remote Participation This is a decentralized, online-only registry. Participation is conducted entirely through a secure web-based portal. There are no physical site visits or travel requirements; participants can contribute from any location with internet access.
Participation Details
Consent: Informed consent is completed electronically.
Surveys: Participants complete electronic surveys upon enrollment and every six months thereafter.
Data Types: Collected data is self-reported and includes demographics, diagnosis history, treatment information, and patient-reported outcomes (PROs), such as quality of life.
Purpose and Data Use The LFA uses registry data to:
Address Constituent Needs: Inform programs and resources for the lupus community.
Advance Research: Share patient insights with to ensure therapies are developed with the consideration of what matters and what matters most to people living with lupus.
Patient Engagement and Clinical Research Matching: Participants may be contacted to assess eligibility for patient engagement or clinical research opportunities or to complete specific sub-surveys regarding trial participation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
is 18 years of age or older
has a self-reported diagnosis of lupus by a physician or health care provider
is willing and able to provide informed consent
is able to read and understand English sufficiently to complete the survey questions
Disqualifiers
People who are not living with lupus
Trial population
People diagnosed with systemic lupus erythematosus, lupus nephritis (lupus-related kidney disease), Cutaneous lupus erythematosus (CLE) or discoid lupus erythematosus (DLE)
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Functional Assessment of Chronic Illness Therapy-Fatigue Scale
This 13-item scale measures self-report fatigue and impacts on activities of daily living and functioning. The scale as been validated in various disease areas including cancer patients, cancer survivors, rheumatoid arthritis and systemic lupus erythematosus.
Work Productivity and Activity Impairment
This outcome measure evaluates impairments over the past 7 days in both paid and unpaid work due to an individual\'s health.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.